Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:
- National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
- Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
- Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
- Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:
- Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
- MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
- Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.
Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.
Leidos (NYSE: LDOS), a FORTUNE 500® leader in science and technology, will participate in the Credit Suisse 8th Annual Virtual Industrials Conference on December 2, 2020, at 3:10 p.m. ET.
Jim Reagan, Executive Vice President and CFO, will engage in a 'fireside chat' during the event. A live audio webcast will be accessible on the Leidos Investor Relations website, with a replay available for 30 days post-event. Leidos reported approximately $11.09 billion in annual revenues for the fiscal year ending January 3, 2020, and employs about 38,000 people across various sectors.
Leidos (NYSE: LDOS) was awarded a cost-plus-fixed-fee contract by Naval Medical Logistics Command worth up to $82 million for operational medicine and warfighter performance research. This contract spans 60 months and will be executed primarily at the Naval Health Research Center in San Diego, California. The research will enhance military health and support the Department of Defense's operational readiness through data-driven modeling and human performance analysis, focusing on improving mission readiness and resilience among military personnel.
The Leidos Partnership for Defense Health has announced further deployments of the MHS GENESIS electronic health record system at military treatment facilities in Nevada, California, and Alaska. This initiative, which started in 2015, aims to streamline health records for millions of service members and their families. Up to 10,000 clinicians can now access a unified health record. Recent waves have included significant expansions for the U.S. Coast Guard, with full deployment expected by the end of 2023.
Leidos Holdings reported third-quarter revenues of $3.24 billion, a 14.4% increase from the previous year, attributed to acquisitions of Dynetics and L3Harris Technologies' SD&A Businesses. Operating income rose to $258 million with a margin decrease to 8.0%. Diluted EPS reached $1.13, slightly up from $1.11. The company revised fiscal 2020 guidance, projecting revenues between $12.3 billion and $12.5 billion and non-GAAP diluted EPS of $5.65 to $5.85. Backlog stands at $31.7 billion.
Leidos Holdings, Inc. (NYSE: LDOS) has declared a quarterly cash dividend of $0.34 per share, payable on Dec. 31, 2020, to stockholders of record as of Dec. 15, 2020. The announcement reflects the company's ongoing commitment to returning value to its shareholders. For the fiscal year ended January 3, 2020, Leidos reported annual revenues of approximately $11.09 billion.
Leidos (NYSE:LDOS) announced on October 29, 2020, a contract award from the Office of the Under Secretary of Defense for Personnel and Readiness worth approximately $75 million. The contract includes a one-year base period and four additional one-year options, primarily based in San Antonio, Texas. Leidos will support the Defense Civilian Human Resource Management System (DCHRMS), integrating six databases to enhance efficiency and reduce costs for DoD HR professionals and civilian employees.
Leidos (NYSE:LDOS) has secured a follow-on contract valued at $306 million from Army Contracting Command to provide comprehensive operations for the Saturn Arch aircraft. This contract features a one-year base period with two additional one-year options and a six-month extension, taking place at Bridgewater Airport, Virginia, and various OCONUS sites. Leidos aims to leverage its expertise in aerial intelligence systems for engineering and technical enhancements. Annual revenues reported for FY 2020 were approximately $11.09 billion.
On October 5, 2020, Leidos (NYSE: LDOS) announced the pricing of $1 billion in senior unsecured notes, with a 2.300% interest rate due in 2031. These notes will be fully guaranteed by Leidos and are intended for qualified institutional buyers. Proceeds will be used for general corporate purposes, including debt repayment. The offering is expected to close on October 8, 2020, subject to standard conditions. This issuance strengthens Leidos' financial position while allowing it to manage its loan facilities more effectively.
Leidos Holdings, Inc. (NYSE: LDOS) plans to initiate a private offering of senior unsecured notes under Rule 144A and Regulation S. The Issuer, Leidos, Inc., will use proceeds primarily for general corporate purposes, including repaying existing loans. The notes will be guaranteed by Leidos and subordinate to existing subsidiary liabilities. This offering targets qualified institutional buyers in the U.S. and non-U.S. persons abroad, without registration under the Securities Act. As of January 3, 2020, Leidos reported annual revenues of approximately $11.09 billion.
FAQ
What is the current stock price of Leidos Holdings (LDOS)?
What is the market cap of Leidos Holdings (LDOS)?
What does Leidos Holdings, Inc. do?
Where is Leidos Holdings, Inc. headquartered?
How many employees does Leidos have?
What are the main business segments of Leidos?
What were Leidos' revenues for the fiscal year 2023?
What is C2IMERA?
What is MHS GENESIS?
What recent project has Leidos completed for the Air Force Research Lab?
What are the recent financial highlights for Leidos?